Gemcitabine and Nabpaclitaxel in Metastatic Pancreatic Carcinoma.
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Metastatic Pancreatic Cancer
Related studies linked through entity extraction aliases.
EL CENTRO: Engaging Latinos in the Center of Cancer Treatment Options
- Status
- COMPLETED
- Phase
- NA
QUILT-3.088: NANT Pancreatic Cancer Vaccine
- Status
- WITHDRAWN
- Phase
- PHASE2
Efficacy and Safety of Modified Nab-Paclitaxel Plus Gemcitabine Chemotherapy for Metastatic Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
First-line Therapy in Metastatic PDAC
- Status
- UNKNOWN
- Phase
- PHASE2
2nd-line Therapy With Nal-IRI After Gem/Nab-pac in Advanced Pancreatic Cancer - Predictive Role of 1st-line Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Post Marketing Surveillance Study for ONIVYDE® in South Korea
- Status
- COMPLETED
- Phase
- N/A
A Study of CPI-613 With Gemcitabine and Nab-paclitaxel for Patients With Advanced or Metastatic Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of ASN007 in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1 Trial of Interleukin 12 Gene Therapy for Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
RX-3117 in Combination With Abraxane® in Subjects With Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Olaptesed (NOX-A12) Alone and in Combination With Pembrolizumab in Colorectal and Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab (LY3012207) in Participants With Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Patient Reported Outcomes Registry in Patient With Cancer Cachexia
- Status
- COMPLETED
- Phase
- N/A
Afatinib and Gemcitabine/Nab-paclitaxel in Metastatic Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Molecularly Tailored Therapy to Standard of Care as Second-Line Therapy in Metastatic Pancreatic Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2